Prognostic significance of metallothionein in human gastrointestinal cancer

Clinical Cancer Research

Volumn 8, Issue 6, 2002, Pages 1889-1896

  Janssen, A Miranda L ^a   Van Duijn, Wim ^a   Kubben, Frank J G M ^a   Griffioen, Gerrit ^a   Lamers, Cornelis B H W ^a   Van Krieken, Johan H J M ^a,b   Van de Velde, Cornelis J H ^a   Verspaget, Hein W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOTHIONEIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIOIMMUNOASSAY; STOMACH CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; METALLOTHIONEIN; MIDDLE AGED; MUCOUS MEMBRANE; PROGNOSIS; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; SURVIVAL RATE;

EID: 0036284478     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Overview of metallothionein
2. Metallothionein in physiological and physiopathological processes
3. Oxygen free radicals and metallothionein
4. Roles of oxygen free radicals in the molecular mechanisms of carcinogenesis: A review
5. Radiation and chemically induced transformation: Free radicals, antioxidants, and cancer
6. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer
7. Antioxidant enzyme levels in cancer
8. Role of superoxide dismutase in cancer: A review
9. Role of superoxide dismutase in modification of radiation injury
10. Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer
11. National Cancer Institute workshop on the possible roles of metallothionein in carcinogenesis
12. Role of metallothionein in carcinogenesis
13. Superoxide dismutases in the human colorectal cancer sequence
14. Superoxide dismutases in relation to the overall survival of colorectal cancer patients
15. Superoxide dismutases in gastric and esophageal cancer and the pronostic impact in gastric cancer
16. Immunohistochemical metallothionein expression in colorectal adenocarcinoma: Correlation with tumor stage and patient survival
17. Absence of immunohistochemical metallothionein staining in bladder tumor specimens predicts response to neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy
18. Immunohistochemical study of metallothionein in pancreatic carcinomas
19. Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology, and prognosis
20. Localization of metallothionein in breast carcinomas. An immunohistochemical study
21. Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases
22. Metallothionein expression in duct carcinoma in situ of the breast
23. Overexpression of metallothionein correlates with chemoresistance to cisplatin and prognosis in esophageal cancer
24. Expression of resistance-related proteins in tumoral and peritumoral tissues of patients with lung cancer
25. Immunohistochemical expression of metallothionein in normal human colorectal mucosa, in adenomas and in adenocarcinomas and their associated metastases
26. Prognostic significance of the expressions of metallothionein, glutathione-S-transferase-π, and P-glycoprotein in curatively resected gastric cancer
27. Metallothionein in human gastrointestinal cancer
28. Gene expression analysis in colorectal cancer using practical DNA array filter
29. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma
30. Neoplasia-related changes of two copper (Cu)/Zinc (Zn) proteins in the human colon
31. Protein measurement with the folin phenol reagent
32. Development of a radioimmunoassay for human metallothionein
33. Regression models and life-tables
34. Nonparametric estimation from incomplete observations
35. Metallothionein expression in human breast cancer
36. Presence and possible significance of immunohistochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast
37. Immunohistochemically demonstrated metallothionein expression in malignant melanoma
38. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival
39. Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus
40. Metallothionein expression in renal cell carcinoma: Subcellular localization and prognostic significance
41. Metallothionein expression in patients with small cell carcinoma of the lung. Correlation with other molecular markers and clinical outcome
42. Concurrent expressions of metallothionein, glutathione S-transferase-π, and P-glycoprotein in colorectal cancers
43. Prognostic evaluation of metallothionein expression in human colorectal neoplasms
44. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer
45. Significance of metallothionein overexpression in human tumours
46. Metallothionein as an epithelial proliferative compartment marker for DNA flow cytometry
47. Cell cycle regulation of metallothionein in human colonic cancer cells
48. Metallothionein expression prevents apoptosis: A study with antisense phosphorothioate oligodeoxynucleotides in a human T cell line
49. Enhanced apoptosis in metallothionein null cells
50. Tumor cell growth is inhibited by suppressing metallothionein-I synthesis
51. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells
52. Resistance against cis-dichlorodiamineplatinum in cultured cells with a high content of metallothionein
53. Increased resistance to chlorambucil in cultured cells with a high concentration of cytoplasmic metallothionein
54. Overexpressed human metallothionein IIA gene protects Chinese hamster ovary cells from killing by alkylating agents
55. Overexpression of metallothionein in CHO cells and its effect on cell killing by ionizing radiation and alkylating agents
56. Differential effects on cell killing in metallothionein overexpressing CHO mutant cell lines
57. Overexpression of metallothionein confers resistance to anticancer drugs
58. Metallothionein induction and deinduction in human prostatic carcinoma cells: Relationship with resistance and sensitivity to adriamycin
59. Metallothionein induction prevents toxic side effects of cisplatin and adriamycin used in combination
60. Prevention of adverse effects of γ-ray irradiation after metallothionein induction by bismuth subnitrate in mice
61. Inhibition of hydroxyl-radical-generated DNA degradation by metallothionein
62. Metallothionein protects DNA from oxidative damage
63. V79 Chinese-hamster cells rendered resistant to high cadmium concentration also become resistant to oxidative stress
64. Cytoplasmic metallothionein overexpression protects NIH3T3 cells from tert-butyl hydroperoxide toxicity
65. Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide